Company / Cash & Equivalents
Equillium, Inc. Cash & Equivalents History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$30.3M
FY2025
5-year range
$18.1M / $59.1M
FY2022-FY2025
Trend
+67.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents returned to growth in FY2025 after 2 years of decline, reaching $30M.
Based on SEC 10-K filings.
$30M in FY2025 with a 3-year CAGR of -20.0%.
Improved from $23M to $30M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -20.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -20.0%, indicating a declining trend.
- In FY2025, cash & equivalents increased 67.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $30.3M | +67.4% |
| FY2024 | $18.1M | -22.1% |
| FY2023 | $23.2M | -60.7% |
| FY2022 | $59.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026